Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EMA Takes Over Permanent Secretariat For Medical Device And IVD Expert Panels

Executive Summary

Despite resistance from the medtech industry, the European Medicines Agency now has a key role in the medical device and IVD expert panels, which have only recently been set up.

You may also be interested in...



Expert Panels To Offer Some Device Manufacturers Scientific Advice Under EU Pilot

Manufacturers of high-risk class III medical devices and class IIb active medical devices that administer or remove medicinal products from the human body will be able to access expert panel advice prior to applying for CE-marking under a newly-announced European Medicines Agency pilot scheme.

MedTech Forum 2022: How Regulatory Complexity Is Crushing The EU

Is it time to reflect on how the EU can take measures to escape a situation where regulation threatens innovation, product availability and product costs and to stop this trajectory of ever increasing the regulatory bar?

EMA’s New Emergency Task Force Gets ‘Balanced’ COVID-19 Expertise

The task force, which is a key component of the European Medicines Agency’s extended mandate, will include experts in the fields of vaccinology, antivirals, clinical trials, immunology and immunotherapy.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel